• Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 10 Mar 2025 01:21:17   America/Chicago


    Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads Beam Therapeutics Inc. ( NASDAQ:BEAM - Get Free Report ) has been a
    Read more...
Share on,